[Generics: essentially similar, bioequivalent but not identical].


The using of generic forms (GF) is presented as a potential source of budgetary "saving of money" in the field of pharmaceutical expenses. Not frequently prescribed in Belgium, they win a new interest thanks to the recent making use of the "reference repayment". Sale's authorization of GF is controlled by european rules, but some questions about their… (More)


Cite this paper

@article{EvenAdin2001GenericsES, title={[Generics: essentially similar, bioequivalent but not identical].}, author={D Even-Adin and J A de Muylder and J E Sternon}, journal={Revue medicale de Bruxelles}, year={2001}, volume={22 6}, pages={513-20} }